|
🐜
|
Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease
8 auth.
R. Wakefield,
Michael J. Green,
H. Marzo-Ortega,
P. Conaghan,
W. Gibbon,
D. McGonagle,
...
S. Proudman,
P. Emery
|
8 |
2004 |
8
🐜
|
|
🐜
|
Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis.
12 auth.
P. Conaghan,
P. O'connor,
D. McGonagle,
P. Astin,
R. Wakefield,
W. Gibbon,
...
M. Quinn,
Z. Karim,
Michael J. Green,
S. Proudman,
J. Isaacs,
P. Emery
|
8 |
2003 |
8
🐜
|
|
🐜
|
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee
11 auth.
S. Cohen,
S. Proudman,
A. Kivitz,
F. Burch,
J. Donohue,
D. Burstein,
...
Yu‐Nien Sun,
C. Banfield,
M. Vincent,
Liyun Ni,
D. Zack
|
7 |
2011 |
7
🐜
|
|
🐜
|
Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope.
8 auth.
Michael J. Green,
H. Marzo-Ortega,
D. McGonagle,
R. Wakefield,
S. Proudman,
P. Conaghan,
...
J. Gooi,
P. Emery
|
7 |
1999 |
7
🐜
|
|
🐜
|
Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.
16 auth.
O. Moore,
N. Goh,
T. Corte,
H. Rouse,
O. Hennessy,
V. Thakkar,
J. Byron,
J. Sahhar,
J. Roddy,
E. Gabbay,
...
P. Youssef,
P. Nash,
J. Zochling,
S. Proudman,
W. Stevens,
M. Nikpour
|
7 |
2013 |
7
🐜
|
|
🐜
|
Early Mortality in a Multinational Systemic Sclerosis Inception Cohort
12 auth.
Y. Hao,
M. Hudson,
M. Baron,
P. Carreira,
W. Stevens,
C. Rabusa,
...
S. Tatibouet,
L. Carmona,
B. Joven,
M. Huq,
S. Proudman,
M. Nikpour
|
7 |
2017 |
7
🐜
|
|
🐜
|
Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort
11 auth.
M. Nikpour,
P. Hissaria,
J. Byron,
J. Sahhar,
Maree Micallef,
W. Paspaliaris,
...
J. Roddy,
P. Nash,
A. Sturgess,
S. Proudman,
W. Stevens
|
7 |
2011 |
7
🐜
|
|
🐜
|
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) — Report from OMERACT CTD-ILD Working Group
11 auth.
D. Khanna,
S. Mittoo,
R. Aggarwal,
S. Proudman,
N. Dalbeth,
E. Matteson,
...
K. Brown,
K. Flaherty,
A. Wells,
J. Seibold,
V. Strand
|
7 |
2015 |
7
🐜
|
|
🦁
|
Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use
10 auth.
S. Proudman,
M. James,
L. Spargo,
R. Metcalf,
T. Sullivan,
M. Rischmueller,
...
Katerina Flabouris,
M. Wechalekar,
Anita Lee,
L. Cleland
|
7 |
2013 |
7
🦁
|
|
🐜
|
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
42 auth.
E. López-Isac,
M. Acosta-Herrera,
M. Kerick,
S. Assassi,
Ansuman T. Satpathy,
Jeffrey M. Granja,
Maxwell R Mumbach,
L. Beretta,
C. Simeón,
P. Carreira,
N. Ortego-Centeno,
I. Castellví,
L. Bossini‐Castillo,
F. Carmona,
G. Orozco,
...
N. Hunzelmann,
J. Distler,
A. Franke,
C. Lunardi,
G. Moroncini,
A. Gabrielli,
J. D. de Vries-Bouwstra,
C. Wijmenga,
B. Koeleman,
A. Nordin,
L. Padyukov,
A. Hoffmann-Vold,
B. Lie,
S. Proudman,
W. Stevens,
M. Nikpour,
T. Vyse,
A. Herrick,
Jane Worthington,
C. Denton,
Y. Allanore,
M. Brown,
T. Radstake,
C. Fonseca,
Howard Y. Chang,
M. Mayes,
Javier Martín
|
7 |
2019 |
7
🐜
|
|
🐬
|
Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis.
S. Kaur,
R. Bright,
S. Proudman,
S. Proudman,
P. Bartold
|
7 |
2014 |
7
🐬
|
